Zymeworks (ZYME) Interest Coverage Ratio (2021 - 2026)
Zymeworks (ZYME) posted Interest Coverage Ratio of 2.43 for Q1 2026, up 94.11% sequentially from 41.26 in Q4 2025, and up 90.06% YoY from 1.28 in Q1 2025.
Zymeworks (ZYME) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Zymeworks has reported Interest Coverage Ratio for 6 years, with the latest figure at 2.43 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 90.06% year-over-year to 2.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.88 (up 81.83% YoY) and the FY2025 annual result came in at 0.34, up 38.71% from the prior year.
- Interest Coverage Ratio climbed to 2.43 in Q1 2026 per ZYME's latest filing, from 41.26 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 289.57 in Q4 2022 and troughed at 48.68 in Q2 2024.
- A 5-year average of 2.89 and a median of 17.31 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 4037.81% in 2022, then slumped 3216.27% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 289.57 in 2022, then slumped by 105.98% to 17.31 in 2023, then plunged by 34.11% to 23.22 in 2024, then plunged by 77.74% to 41.26 in 2025, then surged by 94.11% to 2.43 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.43, 41.26, and 20.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Zymeworks | 1.79 Bn | 1.52 Bn | - | -0.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.49 |
| Mar 31, 2026 | -2.43 |
| Dec 31, 2025 | -41.26 |
| Sep 30, 2025 | -20.53 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -24.44 |
| Dec 31, 2024 | -23.22 |
| Sep 30, 2024 | -35.15 |
| Jun 30, 2024 | -48.68 |
| Mar 31, 2024 | -28.19 |
| Dec 31, 2023 | -17.31 |
| Sep 30, 2023 | -1.07 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -0.85 |
| Dec 31, 2022 | 289.57 |
| Sep 30, 2022 | -1.43 |
| Dec 31, 2021 | -7.35 |